Literature DB >> 26436650

MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes.

Junnan Wu, Chunxia Zheng, Xiao Wang, Shifeng Yun, Yue Zhao, Lin Liu, Yuqiu Lu, Yuting Ye, Xiaodong Zhu, Changming Zhang, Shaolin Shi, Zhihong Liu.   

Abstract

Calcium/calcineurin signaling is critical for normal cellular physiology. Abnormalities in this pathway cause many diseases, including podocytopathy; therefore, understanding the mechanisms that underlie the regulation of calcium/calcineurin signaling is essential. Here, we showed that critical components of calcium/calcineurin signaling, including TRPC6, PPP3CA, PPP3CB, PPP3R1, and NFATC3, are the targets of the microRNA-30 family (miR-30s). We found that these 5 genes are highly expressed as mRNA, but the level of the proteins is low in normal podocytes. Conversely, protein levels were markedly elevated in podocytes from rats treated with puromycin aminonucleoside (PAN) and from patients with focal segmental glomerulosclerosis (FSGS). In both FSGS patients and PAN-treated rats, miR-30s were downregulated in podocytes. In cultured podocytes, PAN or a miR-30 sponge increased TRPC6, PPP3CA, PPP3CB, PPP3R1, and NFATC3 expression; calcium influx; intracellular Ca2+ concentration; and calcineurin activity. Moreover, NFATC3 nuclear translocation, synaptopodin degradation, integrin β3 (ITGB3) activation, and actin fiber loss, which are downstream of calcium/calcineurin signaling, were induced by miR-30 reduction but blocked by the calcineurin inhibitor FK506. Podocyte-specific expression of the miR-30 sponge in mice increased calcium/calcineurin pathway component protein expression and calcineurin activity. The mice developed podocyte foot process effacement and proteinuria, which were prevented by FK506. miR-30s also regulated calcium/calcineurin signaling in cardiomyocytes. Together, our results identify miR-30s as essential regulators of calcium/calcineurin signaling.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26436650      PMCID: PMC4639992          DOI: 10.1172/JCI81061

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  66 in total

1.  Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD.

Authors:  H G Wang; N Pathan; I M Ethell; S Krajewski; Y Yamaguchi; F Shibasaki; F McKeon; T Bobo; T F Franke; J C Reed
Journal:  Science       Date:  1999-04-09       Impact factor: 47.728

Review 2.  The podocyte's response to injury: role in proteinuria and glomerulosclerosis.

Authors:  S J Shankland
Journal:  Kidney Int       Date:  2006-05-10       Impact factor: 10.612

3.  High glucose-induced apoptosis in cultured podocytes involves TRPC6-dependent calcium entry via the RhoA/ROCK pathway.

Authors:  He Yang; Bo Zhao; Chang Liao; Rui Zhang; Kexin Meng; Jia Xu; Jundong Jiao
Journal:  Biochem Biophys Res Commun       Date:  2013-04-06       Impact factor: 3.575

4.  Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo.

Authors:  Liming Wang; Jae-Hyung Chang; Seung-Yeol Paik; Yuping Tang; William Eisner; Robert F Spurney
Journal:  Mol Endocrinol       Date:  2011-05-26

5.  Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy.

Authors:  Xiaojie Wang; Jiang Liu; Junhui Zhen; Chun Zhang; Qiang Wan; Guangyi Liu; Xinbing Wei; Yan Zhang; Ziying Wang; Huirong Han; Huiyan Xu; Chanchan Bao; Zhenyu Song; Xiumei Zhang; Ningjun Li; Fan Yi
Journal:  Kidney Int       Date:  2014-04-09       Impact factor: 10.612

6.  Activation of NFAT signaling in podocytes causes glomerulosclerosis.

Authors:  Yinqiu Wang; George Jarad; Piyush Tripathi; Minggui Pan; Jeanette Cunningham; Daniel R Martin; Helen Liapis; Jeffrey H Miner; Feng Chen
Journal:  J Am Soc Nephrol       Date:  2010-07-22       Impact factor: 10.121

7.  The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury.

Authors:  Bin Zhang; Wei Shi; Juan Ma; Alexis Sloan; Christian Faul; Changli Wei; Jochen Reiser; Yun Yang; Shuangxin Liu; Wenjian Wang
Journal:  J Mol Med (Berl)       Date:  2012-09-27       Impact factor: 4.599

Review 8.  Role of calcineurin in neurodegeneration produced by misfolded proteins and endoplasmic reticulum stress.

Authors:  Abhisek Mukherjee; Claudio Soto
Journal:  Curr Opin Cell Biol       Date:  2011-02-02       Impact factor: 8.382

9.  Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells.

Authors:  F Yu; H Deng; H Yao; Q Liu; F Su; E Song
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

10.  Attenuation of store-operated Ca2+ current impairs salivary gland fluid secretion in TRPC1(-/-) mice.

Authors:  Xibao Liu; Kwong Tai Cheng; Bidhan C Bandyopadhyay; Biswaranjan Pani; Alexander Dietrich; Biman C Paria; William D Swaim; David Beech; Eda Yildrim; Brij B Singh; Lutz Birnbaumer; Indu S Ambudkar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-23       Impact factor: 11.205

View more
  49 in total

Review 1.  A Land of Controversy: Fibroblast Growth Factor-23 and Uremic Cardiac Hypertrophy.

Authors:  Jing-Fu Bao; Pan-Pan Hu; Qin-Ying She; Aiqing Li
Journal:  J Am Soc Nephrol       Date:  2020-06-11       Impact factor: 10.121

Review 2.  Drug discovery in focal and segmental glomerulosclerosis.

Authors:  Nick Pullen; Alessia Fornoni
Journal:  Kidney Int       Date:  2016-04-23       Impact factor: 10.612

3.  Stop TRPC5 in Kidney Disease: A Game Changer for Renal Allograft Protection?

Authors:  Xuexiang Wang; Jochen Reiser
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

4.  Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy.

Authors:  Mariana Cardenas-Gonzalez; Anand Srivastava; Mira Pavkovic; Vanesa Bijol; Helmut G Rennke; Isaac E Stillman; Xiaolan Zhang; Samir Parikh; Brad H Rovin; Maryam Afkarian; Ian H de Boer; Jonathan Himmelfarb; Sushrut S Waikar; Vishal S Vaidya
Journal:  Clin Chem       Date:  2017-06-30       Impact factor: 8.327

5.  Tissue-Specific MicroRNA Expression Patterns in Four Types of Kidney Disease.

Authors:  Maria Angeles Baker; Seth J Davis; Pengyuan Liu; Xiaoqing Pan; Anna Marie Williams; Kenneth A Iczkowski; Sean T Gallagher; Kaylee Bishop; Kevin R Regner; Yong Liu; Mingyu Liang
Journal:  J Am Soc Nephrol       Date:  2017-06-29       Impact factor: 10.121

Review 6.  Targeting the podocyte cytoskeleton: from pathogenesis to therapy in proteinuric kidney disease.

Authors:  Xuefei Tian; Shuta Ishibe
Journal:  Nephrol Dial Transplant       Date:  2016-03-10       Impact factor: 5.992

7.  Angiotensin II induces calcium/calcineurin signaling and podocyte injury by downregulating microRNA-30 family members.

Authors:  Yue Zhao; Junnan Wu; Mingchao Zhang; Minlin Zhou; Feng Xu; Xiaodong Zhu; Xianguang Zhou; Yue Lang; Fan Yang; Shifeng Yun; Shaolin Shi; Zhihong Liu
Journal:  J Mol Med (Berl)       Date:  2017-05-24       Impact factor: 4.599

Review 8.  MicroRNAs as Master Regulators of Glomerular Function in Health and Disease.

Authors:  Piera Trionfini; Ariela Benigni
Journal:  J Am Soc Nephrol       Date:  2017-02-23       Impact factor: 10.121

9.  Triptolide protects podocytes from TGF-β-induced injury by preventing miR-30 downregulation.

Authors:  Qianqian Yang; Mengjie Sun; Ying Chen; Yuqiu Lu; Yuting Ye; Hui Song; Xiaodong Xu; Shaolin Shi; Jinquan Wang
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

10.  Novel calcineurin A (PPP3CA) variant associated with epilepsy, constitutive enzyme activation and downregulation of protein expression.

Authors:  Małgorzata Rydzanicz; Małgorzata Wachowska; Erik C Cook; Paweł Lisowski; Bożena Kuźniewska; Krystyna Szymańska; Sebastian Diecke; Alessandro Prigione; Krzysztof Szczałuba; Aleksandra Szybińska; Agnieszka Koppolu; Victor Murcia Pienkowski; Joanna Kosińska; Małgorzata Wiweger; Grażyna Kostrzewa; Małgorzata Brzozowska; Dorota Domańska-Pakieła; Elżbieta Jurkiewicz; Piotr Stawiński; Agnieszka Gromadka; Piotr Zielenkiewicz; Urszula Demkow; Magdalena Dziembowska; Jacek Kuźnicki; Trevor P Creamer; Rafał Płoski
Journal:  Eur J Hum Genet       Date:  2018-09-25       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.